Madhuri
Madhuri Are, Omaha, NE US
Patent application number | Description | Published |
---|---|---|
20130253368 | PORTABLE LAPAROSCOPE SYSTEM - A portable laparoscope is disclosed. In implementations, the portable laparoscope includes a housing and an elongated tube coupled to the housing. A lighting source and a camera are disposed proximate to an end of the elongated tube opposite the housing. The camera is configured to capture an image in a viewing area that is illuminated by light provided by the lighting source. The portable laparoscope includes an image display apparatus configured to display the images acquired by the camera and/or to transmit the images to a remote display device. The housing may be configured to hold and position an insufflator. | 09-26-2013 |
Madhuri Chandoor, San Jose, CA US
Patent application number | Description | Published |
---|---|---|
20130006872 | NEAR-FIELD COMMUNICATION BASED PAYMENT METHODS - A method of performing a payment transaction is provided. Transaction information is received from a payee, which has been provided to the payee by a payor using near-field communications and includes a payment amount and payee account information. A transaction authentication request is sent to the payor, and, after a transaction authentication is received from the payor, the payment amount is sent to the payee. After the payment has been completed, a payment confirmation is sent to the payor. A method for processing a payment transaction using a generated remittance key is also provided. The remittance key, which includes an encrypted alphanumeric key having a payment amount and payment provider account information for a payor, is generated and transmitted to a payee who, in turn, transmits the remittance key to a remittance agent. The remittance agent transmits the remittance key and a payment request to a payment provider who processes the request and transmits a payment to the payee. | 01-03-2013 |
20130346173 | Driving New User Acquisition from Payment Transactions - Systems and methods are disclosed for a payment service provider to provide benefits through provisional accounts established at in-store checkout to consumers who do not have accounts with the payment service provider to drive use sign-up. The payment service provider may offer cash paying consumers electronic cash stored in provisional accounts instead of any change at a point-of-sale, or offer credit card paying consumers a guest checkout experience to receive discounts, incentives, or rewards. The consumers are asked to provide identifying information such as a phone number of their mobile devices. A provisional account is established and linked it to the identification information if the provisional account does not already exist. Otherwise, the payment service provider may verify that the provisional account has not expired. The payment service provider may send reminders to the mobile devices to encourage the consumers to register an account before the provisional account expires. | 12-26-2013 |
Madhuri Hanwate, Bangalore IN
Patent application number | Description | Published |
---|---|---|
20100105132 | Human Mesenchymal stem cells and preparation thereof - The present invention provides a process of isolation, proliferation and/or maintenance of mesenchymal stem cells (MSCs). The invention further provides a culture medium for proliferation and/or maintenance of human mesenchymal stem cells in xeno-free conditions. The culture medium provided in the present invention proliferates and/or maintains mesenchymal stem cell expansion while maintaining a multipotent phenotype. | 04-29-2010 |
Madhuri Kolhatkar, Englewood, CO US
Patent application number | Description | Published |
---|---|---|
20120117493 | CONFIGURABLE METRIC GROUPS FOR PRESENTING DATA TO A USER - A dashboard application can enable a user to quickly view data (and, in a particular aspect, data from one or more business applications) in an efficient manner. The dashboard application can be used to view data about one or more metrics that reflect the performance of a business, as derived from data maintained (perhaps in an associated data store) by the business application(s). In an aspect, a user can select two or more metrics to be displayed on a summary page and/or can invoke a detail page to view detailed information about one of the two or more metrics. | 05-10-2012 |
Madhuri Nallabolu, Sunnyvale, CA US
Patent application number | Description | Published |
---|---|---|
20140035011 | METHODS AND DEVICES FOR FORMING NANOSTRUCTURE MONOLAYERS AND DEVICES INCLUDING SUCH MONOLAYERS - Methods for forming or patterning nanostructure arrays are provided. The methods involve formation of arrays on coatings comprising nanostructure association groups, formation of arrays in spin-on-dielectrics, solvent annealing after nanostructure deposition, patterning using resist, and/or use of devices that facilitate array formation. Related devices for forming nanostructure arrays are also provided, as are devices including nanostructure arrays (e.g., memory devices). Methods for protecting nanostructures from fusion during high temperature processing also are provided. | 02-06-2014 |
Madhuri Sankaranarayanapillai, Houston, TX US
Patent application number | Description | Published |
---|---|---|
20100062465 | Detection of Histone Deacetylase Inhibition - Provided are compositions and methods for intracellular detection of enzyme activity. One example of a composition is a histone deacetylase substrate comprising a compound of the following formula (I): One example of a method is a method for detecting histone deacetylase activity comprising introducing a compound according to formula (1) to a plurality of cells and monitoring the cells with magnetic resonance spectroscopy. | 03-11-2010 |
20110312007 | Detection of Histone Deacetylase Inhibition - Provided are compositions and methods for intracellular detection of enzyme activity. One example of a composition is a histone deacetylase substrate comprising a compound of the following formula (I): | 12-22-2011 |
Madhuri Sankaranatayanapillai, Houston, TX US
Patent application number | Description | Published |
---|---|---|
20100278730 | Non-Invasive Molecular Imaging of Cellular Histone Deacetylase Substrate Using Magnetic Resonance Spectroscopy (MRS) or Positron Emission Tomography (PET) - We disclose methods of detecting histone deacetylase activity in a mammal by administering to the mammal a compound comprising at least one atom having a nucleus detectable by magnetic resonance spectroscopy, wherein the compound is a substrate of histone deacetylase; and observing the compound or a cleavage product thereof in at least a portion of the body of the mammal by magnetic resonance spectroscopy (MRS). We also disclose methods of detecting histone deacetylase activity in a mammal by administering to the mammal a compound comprising at least one positron-emission-decaying radioisotope, wherein the compound is a substrate of histone deacetylase; and observing the compound or a cleavage product thereof in at least a portion of the body of the mammal by positron emission tomography (PET). We also disclose compounds useful as histone deacetylase substrates. | 11-04-2010 |
Madhuri Vemulakonda, Sunnyvale, CA US
Patent application number | Description | Published |
---|---|---|
20080209276 | Targeted Regression Testing - A software testing method. In particular implementations, a method includes accessing a first database of one or more bug entries, wherein each but entry comprises information characterizing a bug, an associated code component, and a test script; and a mapping between the component and one or more scripts that test the code component; for one or more bug entries in the first database, determining if the bug is a new bug; if the bug is not a new bug, determining if the test script is new relative to the bug; and if the bug is a new bug or if the test script is new relative to the bug, accessing a second database of the script to component mappings to add a mapping between the test script and the associated code component of a respective bug entry. | 08-28-2008 |
Madhuri Wadehra, Manhattan Beach, CA US
Patent application number | Description | Published |
---|---|---|
20130034555 | EPITHELIAL MEMBRANE PROTEIN 2 (EMP2) BINDING REAGENTS AND THEIR THERAPEUTIC USES IN OCULAR DISEASES - A method is disclosed for treating diseases or disorders of the eye involving undesired expression of vascular endothelial growth factor (VEGF) by administration of endothelial membrane protein 2 (EMP2) inhibitor. The present invention relates to the direct treatment of macular degeneration, particularly age-related macular degeneration (AMD), by administering an EMP2 inhibitor intraocularly or systemically. | 02-07-2013 |
20130230527 | EMP2 ANTIBODIES AND THEIR THERAPEUTIC USES - The present invention provides methods and compositions useful in the treatment or prevention of | 09-05-2013 |
20130344078 | EMP2 ANTIBODIES AND THEIR THERAPEUTIC USES - The present invention provides methods and compositions useful in the treatment or prevention of | 12-26-2013 |
20140072569 | EMP2 ANTIBODIES AND THEIR THERAPEUTIC USES - The present invention provides methods and compositions useful in the treatment or prevention of | 03-13-2014 |
20140234308 | TREATMENT OF BREAST CANCER WITH COMPANION DIAGNOSTIC - Despite advances in therapy, breast cancer remains the most common malignancy in women. Of particular concern is the aggressive triple negative subtype that lacks the BRCA1 mutation, estrogen receptor, and epidermal growth factor type 2 receptor (Her-2/neu), which accounts for approximately half of all breast cancer deaths. Provided herein are compositions and methods for treating breast cancer, including the triple negative subtype. | 08-21-2014 |
20150079089 | EMP2 REGULATES ANGIOGENESIS IN CANCER CELLS THROUGH INDUCTION OF VEGF - Disclosed herein are methods and compositions for modulating neovascularization. The disclosed compositions find particular use in the treatment of uterine cancers, specifically endometrial cancers. | 03-19-2015 |
Madhuri Wadehra, Fontana, CA US
Patent application number | Description | Published |
---|---|---|
20100196509 | Methods for Diagnosis and Treatment of Endometrial Cancer - The present invention discloses methods of using endothelial membrane protein 2 (EMP2) as a biomarker for stratification of endometrial premalignancy, diagnosing, staging and imaging of endometrial neoplasia. Further, methods for identifying pharmaceutical/therapeutic modalities are described, including compositions which modulate glycolipid-enriched lipid raft microdomains (GEMs). | 08-05-2010 |
20100272732 | EMP2 ANTIBODIES AND THEIR THERAPEUTIC USES - The present invention provides methods and compositions useful in the treatment or prevention of | 10-28-2010 |
20120020983 | EMP2 ANTIBODIES AND THEIR THERAPEUTIC USES - The present invention provides methods and compositions useful in the treatment or prevention of | 01-26-2012 |
20120264620 | METHODS FOR DIAGNOSIS AND TREATMENT OF ENDOMETRIAL CANCER - The present invention discloses methods of using endothelial membrane protein 2 (EMP2) as a biomarker for stratification of endometrial premalignancy, diagnosing, staging and imaging of endometrial neoplasia. Further, methods for identifying pharmaceutical/therapeutic modalities are described, including compositions which modulate glycolipid-enriched lipid raft microdomains (GEMs). | 10-18-2012 |